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Uptake of Triiodothyronine Sulfate and Suppression of Thyrotropin Secretion in 
Cultured Anterior Pituitary Cells 
M.E. Ever&, T.J. Visser, J.C.J. van Buuren, R. Dotter, M. de Jong, E.P. Krenning, and G. Hennemann 
To investigate the uptake of triiodothyronine sulfate (T$) and its effect on thyrotropin-releasing hormone (TRH)-induced 
thyrotropin (TSH) secretion, anterior pituitary cells were isolated from euthyroid rats and cultured for 3 days in medium 
containing 10% fetal calf serum. Incubation was performed at 37°C in medium containing 0.5% bovine serum albumin (BSA). 
Exposure of the pituitary cells to TRH (0.1 pmol/L) for 2 hours stimulated TSH secretion by 176%. This effect was reduced by 
approximately 45% after a 2-hour preincubation with TO (0.001 to 1 pmol/L). A significant inhibitory effect of TBS on 
TRH-induced TSH release was only observed at a concentration of 1 Fmol/L. The uptake of [1251]T3 after 1 hour of incubation 
was reduced by 40% f 4% (P < .OOl) by simultaneous addition of 10 nmol/L unlabeled TB, whereas 1 pmol/L TBS was required 
to obtain a reduction of the [‘251]T3 uptake by 34% 5 2% (P < .OOl). The amount of T3 present in the unlabeled T$S preparation 
was 0.25% as determined by radioimmunoassay. When pituitary cells were incubated for 1 hour with [1251]T3S or [1251]T3 (both 
50,000 cpm/0.25 mL), the uptake of [1251]T$ expressed as a percentage of the dose was 0.04% f 0.02% (mean + SE, n = 4). 
whereas that of [1251]T3 amounted to 3.0% 2 0.4% (n = 4). In contrast, when hepatocytes were incubated for 1 hour with 
[1251]T3S, the uptake amounted to 5.1% f 0.8% (n = g), whereas that of [1251]T3 was 22.1% f 1.7% (n = 9). Furthermore, [1251]T3S 
was as rapidly deiodinated (iodide production, 14.9% + 2.6%; n = 9) as [‘251]T3 (12.1% f 0.8%, n = 9) by hepatocytes. It is 
concluded that (1) T$ is poorly taken up by pituitary cells, and (2) the suppressive effect of high concentrations of T$ on 
TRH-induced TSH secretion and on [1251]T3 uptake can be explained by slight contamination with Ta. Thus, it appears that TBS 
has only a minor biological effect, if any, on the pituitary. 
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S ULFATION plays a significant role in the metabolism of iodothyronines in both man and animals, although 
it is probably more important for triiodothyronine (Ti) than 
for thyroxine. at least in rats and dogs.lm3 However, during 
nonthyroidal illness (NTI) the contribution of the different 
pathways. ie, deiodination, glucuronidation, and sulfation, 
to thyroid hormone metabolism might change consider- 
ably.4,s Measurements of the hormone levels in sera of NT1 
patients showed that the reduction in serum Tj and 
thyroxine was accompanied by a threefold increase in 
serum T3 sulfate (T$) apart from the known increase in 
serum reverse Tj.h Despite these changes, serum thyrotro- 
pin (TSH) was in the normal range.h 
effects with a potency of approximately 20% that of T+“’ In 
the same study, it was shown that treatment of hypothyroid 
rats with a relatively high dose of T3S resulted in a 
reduction of serum TSH and a normalization of the serum 
Tj level, indicating desulfation of T3S in viva.“’ 
In the study by LoPresti et al.’ the question was raised as 
to whether the increased T3S production might contribute 
to the suppression of TSH secretion during NTI. In their 
experiments, infusion of T3S in healthy volunteers, calcu- 
lated to result in a relatively low serum level of T3S, did not 
reduce the serum TSH level.’ In another study with the 
growth hormone-producing pituitary tumor cell line GH&,, 
it was shown that T$ failed to displace [“‘I]T_~ from the 
nuclear binding sites.x However, the possibility that T3S 
could have thyromimetic activity after desulfation was not 
excluded.x.y More recently, it was reported that administra- 
tion of T3S to hypothyroid rats produced thyromimetic 
Together, these results could be explained by the assump- 
tion that T3S is not taken up by the pituitary, and that the 
effects of TIS in vivo might be due to an effect of T3 (after 
desulfation or due to contamination of T3S). To test this 
hypothesis, the present study was undertaken to examine in 
vitro the effects of T3S on TSH secretion and the uptake of 
[1251]T3S by the pituitary. We used primary cultures of 
anterior pituitary cells of euthyroid rats. This preparation 
contains active thyrotrophs that release TSH in response to 
(TSH-releasing hormone [TRH]) and transport T3 by a 
carrier-mediated mechanism. ‘I Since it is not known whether 
TIS is metabolized in the pituitary like it is in the liver’? and 
whether possible effects of T3S on pituitary function should 
be ascribed to TIS itself or to any metabolic product, we 
have also compared pituitary cells and hepatocytes with 
respect to the uptake and deiodination of [‘2SI]T3S and 
(‘251]T3. 
Animals 
MATERIALS AND METHODS 
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All experiments were performed using male Wistar rats weighing 
220 to 250 g. The animals had free access to food and water and 
were kept in a controlled environment (21°C) with constant day 
length (12 hours). 
Pituitary Cell Culture 
Animals (12 for each experiment) were killed between Y:OO and 
Y:30 AM by decapitation. The pituitary glands were removed within 
5 minutes. the neurointermediate lobe was discarded, and the 
anterior lobes were collected in calcium- and magnesium-free 
Hanks balanced salt solution supplemented with 10 y/L human 
serum albumin, penicillin (lo5 U/L), amphotericin B (Fungizone. 
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Bristol-Myers Squibb, Woerden, The Netherlands; 0.5 mg/L). and were counted for radioactivity in a 16-channel gamma counter (NE 
sodium bicarbonate (0.4 g/L). The anterior pituitary lobes were 1600. Nuclear Enterprises, Sighthill, Edinburgh, Scotland). The 
dissociated with dispase (2.4 x lo3 U/L) as described in detail amount of [1151]Ts or [‘25]T$S taken up by the cells was expressed as 
elsewhere.i3 From each pituitary, 1 to 1.5 x 10h cells were a percentage of the dose. The same procedure was applied to the 
obtained, and the viability of the cells as determined by trypan blue incubations without ceils. All results are corrected for the amount 
exclusion was greater than 90%. of radioactivity retained in the wells without cells. 
The cells were cultured at 37°C in a water-jacketed incubator in 
humidified air with 5% CO? at a density of 3 to 5 x IO5 cells per 
well in 48-well culture dishes. The culture medium consisted of 
Minimal Essential Medium with Earle’s salts supplemented with 
nonessential amino acids, sodium pyruvate (1 mmol/L), 10% fetal 
calf serum. penicillin (lo5 U/L), amphotericin B (0.5 mg/L), 
I.-glutamine (2 mmol/L). and sodium bicarbonate (2.2 g/L, pH 
7.4).i3~“- The cells had attached to the wells after 2 days of culture; 
on day 3, the cells were used for experiments. In a previous study it 
was shown that the TSH content of the pituitary cell preparation 
was highest after this short period of culture.” 
Hepatocytes were incubated with [i151]T3 or [izsI]T3S (both 
100,000 cpmiml) at 37°C for 1 to 120 minutes in 1 mL hepatocyte 
culture medium with 0.5% BSA instead of fetal calf serum. Further 
processing was the same as for pituitary cells. 
Iodide Production 
TSH Secretion 
The culture medium was removed from the cells, and the cells 
were washed once with incubation medium. This medium was 
identical to the culture medium except that the fetal calf serum was 
replaced by 0.5% bovine serum albumin (BSA). The pituitary ceils 
were preincubated for 2 hours at 37°C in the absence or presence 
of variable concentrations of Ts or T$S (0.001 to 1 umol/L). The 
medium was then discarded, and fresh medium was added contain- 
ing TRH (0.1 PmoliL) with or without T3 or T+S. Incubation was 
continued for 2 hours at 37°C and was followed by removal of the 
medium. The cells were washed once with 1 mL ice-cold saline 
(0.9% NaCl). Incubation media were centrifuged (2,000 x g ). and 
the supernatants were frozen for later determination of TSH. 
Incubations were performed in triplicate. 
Aliquots of the incubation medium from the three uptake 
experiments with hepatocytes (Fig 2) and the two experiments with 
pituitary cells (Table 2) were chromatographed on Sephadex 
LH-20.ih Iodide was eluted from the column with 3 x 1 mL O.lN 
HCI. Subsequently, glucuronides and sulfates (conjugates) were 
eluted with 8 x 1 mL H20, and finally the iodothyronines were 
removed from the column with 3 x 1 mL 50% ethanol in O.lN 
NaOH. 
Determination of TSH 
TSH levels in the incubation media were measured by radioim- 
munoassay as previously described.” 
Analysis of T3S 
The purity of the unlabeled TsS preparation was tested by 
conventional radioimmunoassay with two TJ antisera produced in 
our laboratory (no. 7157 and 7160). Both antisera were used in a 
final dilution of 1:200,000. 
Free Tz and T3S Concentrations 
Hepatcqtes 
Hepatocytes were isolated by collagenase perfusion as previously 
described.‘s Cells were cultured at 37°C at a density of 2 x lo6 cells 
per well in 6-well culture dishes in 2 mL Ham’s FlO, HEPES (8.9 
mmol/L), PIPES (10.6 mmol/L), and N,N-bis[2-hydroxyethyll-2- 
aminoethane sulfonic acid ([BES] 11.2 mmol/L) supplemented 
with 10% fetal calf serum, CaClz (2 mmol/L), glucose (6.7 
mmol/L). insulin (12 U/L), and penicillin/streptomycin (5 x lo4 
U/L, pH 7.4). After 4 hours of culture, the cells were washed once 
with rinsing medium and used for experiments.lh 
Calculation of the free T3 and T3S concentrations in the 
experiments was based on the determination of the free fractions 
by equilibrium dialysis. I7 With 0.5% BSA in the incubation 
medium, the free T3 fraction amounted to 2.85% + 0.01% (n = 4), 
and the free TjS fraction to 2.12% (n = 2). The free TsS fraction 
was corrected for the fact that only 60% of the T$i precipitated 
with MgCI?. It was further checked by high-performance liquid 
chromatography that this was not due to the presence of iodide in 
the [iz51]T3S preparation. 
Materials 
Uptake of [‘2sI]T.7 and [t2sI]T~S 
For these studies, cells were cultured as described above. On the 
same culture dishes, an equal number of wells contained only 
culture medium (blanks). All incubations with and without ceils 
were performed in triplicate. 
Pituitary cells were equilibrated in 0.5 mL culture medium 
containing 0.5% BSA. After equilibration for 30 minutes, the 
medium was removed and the cells were incubated for 1 hour at 
37°C with [i”‘I]Ts (50,000 cpm, 50 pmol/L) in 0.25 mL medium 
alone or together with 0.01 to 10 umol/L TX or T3S. The uptake of 
[1z.CI]T3S (50,000 cpm) was measured exactly as for [izsI]T3. 
To allow direct comparison with the hepatocyte experiments, 
two experiments with pituitary cells were performed in incubation 
medium where NaHCOs was replaced by an equimolar amount of 
HEPES (8.9 mmol/L). PIPES (10.6 mmol/L), and BES (11.2 
mmol/L). As previously described, this did not affect the uptake of 
[iz51]T3 by the pituitary cells” (Table 2). 
After incubation, the medium was removed and the cells were 
washed with 1 mL ice-cold saline to remove labeled compounds not 
bound to the cells. Cells were dissolved in 1 mL O.lN NaOH and 
All solutions used for cell isolation and cell culture were 
obtained from GIBCO Europe (Breda, The Netherlands). with the 
exception of human serum albumin (Rhone-Poulenc. Amstelveen, 
The Netherlands), dispase (grade II. Boehringer. Mannheim, 
Germany), and collagenase (type I. Sigma, St Louis, MO). Culture 
dishes (48- and 6-well) were purchased from Costar (Cambridge, 
MA) and Nunc (Roskilde, Denmark), respectively. TRH (Rele- 
fact) was obtained from Hoechst, Frankfurt am Main, Germany. 
Tj, PIPES, HEPES, BES, and BSA (fraction V) were purchased 
from Sigma (St Louis, MO). [3’-iz51]T3 (3,070 uCi/ug) was 
purchased from Amersham International (Aylesbury, Buckingham- 
shire, UK). T+S and [1?51]TsS were prepared from T3 and [“‘I]Tj, 
respectively, using C1S03H.‘8 [iz51]T3S was purified by LH-20 
chromatography, and analysis of the fractions by high-performance 
liquid chromatography’s showed that the preparation consisted of 
98% T3S and contained less than 2% iodide. Reagents for the rat 
TSH radioimmunoassay were kindly provided by the National 
Institute of Diabetes and Digestive and Kidney Diseases (Bethesda, 
MD). Sephadex G25 was obtained from Pharmacia (Uppsala. 
Sweden). All other reagents were of the highest purity available. 
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Statistics 
Significances of differences were calculated with Student’s t test 
for unpaired observations. A P value less than ,021 was regarded as 
statistically significant. 
RESULTS 
Effects of T$ on TSH Secretion 
Table 1 shows a comparison of the effects of various 
concentrations of T3 and T3S on the TRH-induced TSH 
secretion by anterior pituitary cells. When TRH was added 
at a concentration of 0.1 t.r,mol/L, TSH release was stimu- 
lated by 176% (P < .OOl). This effect was reduced by 
approximately 45% after preincubation with 1 kmol/L T3 
or T$ (P < .OOl for both). The inhibitory effect of T3 on 
TRH-induced TSH secretion was the same after preincuba- 
tion with lower concentrations of T3 (0.1 and 0.01 umol/L). 
In contrast, the effect of preincubation with 0.1 kmol/L T3S 
was much smaller (14%, NS), and at 0.01 kmol/L TsS the 
effect was completely absent. An additional experiment was 
performed where the effects of even lower concentrations 
of Ta and TaS on TRH-induced TSH secretion were 
compared. TRH-induced TSH release was inhibited by 
62% (P < .025 or less) at T3 concentrations of 0.01, 0.1, and 
1.0 PmoliL, and by 41% (.05 < P < .lO) at a T3 concentra- 
tion of 0.001 pmol/L. The effect of TsS was absent at 0.001 
and 0.01 p,mol/L, and the maximum effect was obtained at 
a concentration of 1 kmol/L T3S and amounted to 53% 
(P < .025). 
Effects of T3S on [“I/T3 Uptake 
A comparison between the effects of Tj and TsS was also 
made with respect to the uptake of [1251]T3 bythe pituitary 
cells. Figure 1 shows the combined results of three experi- 
ments. In the first experiment with 300,000 cells per well the 
control uptake of [1251]T3 was 1.62% * 0.03% (n = 3), and 
in the second and third experiments with 500,000 cells per 
well it was 3.96% 2 0.15% (n = 3) and 2.39% ? 0.08% 
(n = 5). Simultaneous incubation of the cells with 0.01, 0.1, 
1, and 10 FmoliL unlabeled T3 reduced the uptake of 
Table 1. Effects of T, and T,S on the TRH-Induced Stimulation of 
TSH Release From Anterior Pituitary Cells 
Experimental Conditions TSH Release (ng) Effect 1%) P 
Controls (14) 2.1 f 0.1 
+TRH 0.1 pmol/L (14) 5.8 f 0.2 +176 < ,001 
TRH + T3 1 pmol/L (8) 4.1 k 0.3 +95 <.001x 
TRH + T,.S 1 wmol/L (9) 3.9 + 0.3 +86 <.001* 
TRH + T3 0.1 rmol/L (3) 4.3 2 0.1 +104 < .025* 
TRH + T,S 0.1 pmol/L (6) 5.3 t 0.2 +152 NS* 
TRH + T, 0.01 kmol/L (6) 4.2 i- 0.2 +100 <.001x 
TRH + T3S 0.01 pmol/L (6) 5.7 + 0.1 +171 NS* 
NOTE. Data are the mean + SE of three independent experiments, 
with the number of observations in parentheses. Anterior pituitary cells 
were cultured for 3 days at a density of 5 x lo5 cells/well. The cells were 
preincubated for 2 hours in the absence or presence of T3 (0.01 to 1 
pmol/L) or T3S (0.01 to 1 wmol/L). Then they were incubated with TRH 
(0.1 trmol/L) for 2 hours with or without the additions indicated. 
‘Pvalues calculated compared with the addition of TRH alone. 
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T3 or T3S added (utvt) 
Fig 1. Effects of unlabeled (0) T3 and (01 T,S on the uptake of 
[1Z51]T, by anterior pituitary cells. The cells were cultured for 3 days at 
a density of 3 to 5 x lo5 cells/well. After equilibration, the cells were 
incubated for 1 hour with [9]Ts (50,000 cpm) with various concentra- 
tions of unlabeled T3 or T,S. Data represent the mean + SE of three to 
nine observations from three independent experiments. Significances 
of differences were calculated as compared with the controls (100%): 
l P < ,025, l *P < ,001. 
[1?SI]T3 by 40% + 4% (P < .OOl), 40% +- 5% (P < .OOl), 
52% ? 2% (P < .OOl), and 56% * 1% (P < .OOl), respec- 
tively. When T$S was added at concentrations of 0.01, 0.1, 1, 
or 10 kmol/L, [1151]T3 uptake was reduced by 6% 2 4% 
(NS), 11% + 4% (P < .025), 34% * 2% (P < .OOl). and 
52% ? 5% (P < ,001) respectively. 
Uptake of [‘2sI]T,S by Pituitary Cells and Hepatocytes 
In four experiments with 500,000 cells per well, the 
uptake of [1z51]T3S bypituitary cells was compared with that 
of [1251]T3 (Table 2). After 1 hour of incubation the uptake 
of [1251]T$S was less than O.l%, whereas the mean uptake of 
[L’SI]T3 amounted to 3.0% + 0.4% (Table 2). In contrast, 
both [‘251]T3S and [1”51]T3 were taken up by hepatocytes 
(Fig 2A), although the uptake of [1251]T3 was roughly 
fourfold greater than that of [‘?“I]T3S. The uptake of both 
compounds reached a maximum value between 0.5 and 1 
hour of incubation, and then declined slightly. As can be 
seen from Fig 2B, both T3 and T3S were deiodinated in 
hepatocytes, and iodide production from ]1251]TjS was at 
Table 2. Comparison of the Uptake of [‘2sl]T, and [1*51]T,S in Anterior 
Pituitary Cells 
Experiment No. PIIT3 Uptake (% dose) PllT$ Uptake (% dose) 
1 2.96 ? 0.02 0.01 * 0.04 
2 2.64 2 0.09 0.07 * 0.02 
3 2.34 ? 0.13 0.00 * 0.05 
4 3.96 ? 0.15 0.09 c 0.06 
NOTE. Data represent the mean f SE of triplicate determinations, 
Anterior pituitary cells were cultured for 3 days at a density of 5 x 105 
cells/well. Experiments 1 and 2 were performed in incubation medium 
containing NaHCO,, and experiments 3 and 4 in incubation medium 
containing HEPES, BES, and PIPES. The cells were equilibrated for 30 
minutes in incubation medium and then incubated for 1 hour with 
[‘2511T, or [1251]TsS (both 50,000 cpm/0.25 mL). 
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Time (h) 
Ih 2h 
Fig 2. Time course of the (A) uptake of (0) [‘251]T3 and (0) [‘*sl]T,S 
and (B) iodide production by primary cultures of hepatocytes. Hepato- 
cytes were incubated for periods varying from 1 minute to 2 hours 
with [“51]T3 or [1*sl]T3S (both 100,000 cpm/mL). Iodide production 
after 1 and 2 hours of incubation was measured in the media by LH-20 
chromatography. Data represent the mean r SE of nine observations 
from three independent experiments. (0) Iodide production from 
[1z51]T3; (W] iodide production from [‘“I]T,S. 
least as high as that from [1251]Ts. Furthermore, iodide 
production from TJ and TsS doubled when the incubation 
time was prolonged from 1 to 2 hours. In the same l-hour 
period, the mean conjugate formation from [12sI]T3 was 
4.7% +- 0.8% (not shown). There was no production of 
unconjugated T3 from [1151]T3S by hepatocytes during the 
course of the experiment (not shown). 
To determine if pituitary cells also metabolized T3 and 
T& incubation media from the last two experiments hown 
in Table 2 were analyzed for iodide production. Neither in 
the media from the pituitary cells incubated with [12sI]T3 
nor in those from [1251]TsS incubations was iodide detect- 
able. .After incubation with [1251]T3, no conjugates were 
detected, and 95% of the radioactivity appeared in the 
iodotbyronine fraction. In the case of [l”SI]T$, 90% to 95% 
of the radioactivity was found in the conjugate fraction, and 
no radioactivity was found in the iodothyronine fraction 
(not shown). 
Acriry of Unlabeled T.?,S 
Finally, the amount of Ts present in the unlabeled TsS 
preparation was determined by radioimmunoassay with two 
different antisera, showing that the TsS preparation con- 
tained 0.25% Ta. Incubation medium with 1 pmol/L TsS 
contained 2.49 nmol/L T3 before incubation with cells and 
2.08 + 0.02 (n = 3) nmol/L T3 after incubation with cells. 
DISCUSSION 
The results of the present study indicate that T$ does 
not play a significant role in the suppression of TSH 
secretion in pituitary cells in vitro. Furthermore, our results 
suggest essential differences in the metabolic handling of Tz 
and T$S by pituitary cells and hepatocytes. 
LoPresti et al7 suggested that TsS might play a role in the 
suppression of TSH secretion during NTI. This hypothesis 
seemed already somewhat weakened by their own observa- 
tion that infusion of TsS in healthy volunteers did not result 
in decreased levels of serum TSH. On the other hand, the 
serum level of TsS achieved during the infusion was not 
measured, and the lack of effect of TsS could be due to the 
low calculated TsS/Ta ratio (46%). 
Although 1 Fmol/L TsS was as effective as 1 FmoliL T3 
in suppressing the TRH-induced TSH secretion in our cell 
culture, this effect can simply be explained on the basis of a 
slight contamination of the TsS preparation with Ts. The 
amount of T3 in the unlabeled TsS preparation was 0.25%, 
and hence, 1 kmol/L TsS will roughly contain 2.5 nmol/L 
Ts. This idea was confirmed by the experiment where the 
effect of 1 pmol/L TsS on TRH-induced TSH secretion was 
found to correspond to a value (53%) just between 1 
nmol/L Ts (41%) and 10 nmol/L T3 (62%). 
The effect of unlabeled T$ on the uptake of [1Z51]T3 by
pituitary cells was dose-dependent, and was still lower 
(34% inhibition) when TsS was added at a concentration of 
1 pmol/L as compared with the effect of 10 nmol/L T3 
(40% inhibition). In our previous study,” it was observed 
that addition of 1 nmol/L Ts reduced the uptake of [1251]T3 
by approximately 29%. Thus, the effects of T3S on [1251]T3 
uptake are also compatible with a contamination of the T3S 
preparation with T3 ( < 1%). Our results are also in line 
with those of Spaulding et al,x who apparently used more 
purified T3S and found no displacement of [lzjI]Tj from the 
nuclear receptors in the growth hormone-producing cell 
line GH4CI in the concentration range of 0.001 to 1 kmol/L 
TS. 
The explanation that the effect of high concentrations of 
T$ on TRH-induced TSH secretion or [‘251]T3 uptake is 
due to contamination of the T3S preparation with T3 is also 
supported by our observation that [iZ51]T$S itself was only 
poorly taken up by the pituitary cells. This was concluded 
from a series of experiments where a significant amount of 
[lz51]T3, added at the same radioactive and molar concentra- 
tion as [1251]T3S, was taken up by the pituitary cells. In 
contrast, both [1251]T3 and [‘251]TsS were taken up by 
hepatocytes, although the uptake of [lz51]TJ was roughly 
fourfold higher than that of [iZ51]T3S. On the other hand, 
despite this difference in uptake, iodide production from 
[iSI]T3S was at least as high as that from [1251]T3. This 
indicated that T,S and T3 (after preceding sulfationi9) were 
deiodinated followed by efflux of lzsI- from the liver cells. 
These results also confirmed the previous observation that 
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T3S is a preferred substrate for the liver type I deiodinase, 
being deiodinated successively in the inner and outer 
ring.12,1y During the 2 hours of the experiments, no unconju- 
gated T3 was detectable in the media from hepatocytes 
incubated with [1ZsI]T3S. This seems to be in contrast to the 
observations of Kung et al,1° who reported 1 o/u hydrolysis of 
T$ per hour in isolated hepatocytes. The reason for this 
discrepancy might be that hepatocytes were incubated in 
the presence of T3S in the micromolar range (7 to 50 
kmol/L) in the study by Kung et al,‘” which is far above the 
Km of the type I deiodinase for T3S (4.6 kmol/L”), resulting 
in saturation of the deiodination pathway. In our experi- 
ments, the T3S concentration was in the picomolar range. 
Although the anterior pituitary is generally regarded as 
an organ with a low type I deiodinase activity,” extremely 
rapid deiodination of [1Z51]T3S and efflux of lz51m could 
theoretically account for the observation that cellular up- 
take of [1251]T3S was hardly detectable. It was recently 
reported that the posterior pituitary,“-’ like the brain,‘3 
contains type III deiodinase that would deiodinate T3. This 
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reaction would only be detectable by IzsI- production, if the 
inner-ring deiodination by type III deiodinase is followed 
by outer-ring deiodination. Furthermore, T3S is not a 
substrate for the type III deiodinase.” The LH-20 chroma- 
tography performed in the same way as for the hepatocyte 
experiments showed no IZ51m production from [‘?‘I]T$ or 
from [1Z51]T3 during the hour the experiment lasted. 
Taken together, our results strongly suggest that relative 
to Tj, T$ is poorly taken up by the pituitary gland. In 
addition, it seems that T3S is not hydrolyzed in this tissue, 
and consequently the biological effects of T3S on the 
euthyroid pituitary gland are minimal. 
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